InvestorsHub Logo
Followers 2
Posts 39
Boards Moderated 0
Alias Born 02/28/2019

Re: sharinky post# 222158

Thursday, 10/31/2019 5:02:54 PM

Thursday, October 31, 2019 5:02:54 PM

Post# of 425732
They are not (to my knowledge) running trials. In 2016, they filed aNDAs seeking approval to sell generic V for the approved indication at that time, namely "as an adjunct to diet to reduce triglyceride (“TG”) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia." The filing of the aNDAs triggered the pending lawsuit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News